← Back to home

THE FOCUS OF THE STUDY IS TO DETERMINE THE COMPARATIVE PHARMACODYNAMIC OF ENOXAPARIN SODIUM WITH THAT OF CLEXANE IN HEALTHY HUMAN PARTICIPANTS

Clinical trials for THE FOCUS OF THE STUDY IS TO DETERMINE THE COMPARATIVE PHARMACODYNAMIC OF ENOXAPARIN SODIUM WITH THAT OF CLEXANE IN HEALTHY HUMAN PARTICIPANTS explained in plain language.

Never miss a new study

Get alerted when new THE FOCUS OF THE STUDY IS TO DETERMINE THE COMPARATIVE PHARMACODYNAMIC OF ENOXAPARIN SODIUM WITH THAT OF CLEXANE IN HEALTHY HUMAN PARTICIPANTS trials appear

Sign up with your email to follow new studies for THE FOCUS OF THE STUDY IS TO DETERMINE THE COMPARATIVE PHARMACODYNAMIC OF ENOXAPARIN SODIUM WITH THAT OF CLEXANE IN HEALTHY HUMAN PARTICIPANTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New generic blood thinner put to the test in healthy volunteers

Knowledge-focused Not yet recruiting

This early-stage study checks if a new generic version of the blood thinner enoxaparin works the same as the brand-name drug Clexane. About 26 healthy adults will receive a single dose of each drug, one week apart, and have their blood tested. The goal is to see if the generic is…

Matched conditions: THE FOCUS OF THE STUDY IS TO DETERMINE THE COMPARATIVE PHARMACODYNAMIC OF ENOXAPARIN SODIUM WITH THAT OF CLEXANE IN HEALTHY HUMAN PARTICIPANTS

Phase: PHASE1 • Sponsor: Egyptian International Pharmaceutical Industries Co • Aim: Knowledge-focused

Last updated May 17, 2026 08:00 UTC

THE FOCUS OF THE STUDY IS TO DETERMINE THE COMPARATIVE PHARMACODYNAMIC OF ENOXAPARIN SODIUM WITH THAT OF CLEXANE IN HEALTHY HUMAN PARTICIPANTS

Get alerted when new THE FOCUS OF THE STUDY IS TO DETERMINE THE COMPARATIVE PHARMACODYNAMIC OF ENOXAPARIN SODIUM WITH THAT OF CLEXANE IN HEALTHY HUMAN PARTICIPANTS trials appear

New generic blood thinner put to the test in healthy volunteers